Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 26, Issue 3-4, Pages 223-247Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/08830180701402496
Keywords
tumor associated antigen; biomarker; immune therapy; genomics; proteomics
Categories
Ask authors/readers for more resources
Cancer has currently overtaken heart disease as the major cause of mortality in the United States. The Human Genome Project, advances in inforinatics, miniaturization of sample collection, and increased knowledge of cell signaling pathways has revolutionized the study of disease. Genomics, proteomics, and metabolonlics are currently being used to develop molecular signatures for disease diagnosis, prognosis, and therapeutic efficacy. Tumor-associated antigens discovered by these methods are being used to develop passive (humoral) as well as active immunotherapy strategies to stimulate the immune system, Development and validation of biomarkers on a parallel track with therapeutics can speed development times by accurate screening of patient populations and substituting surrogate markers that correlate well with clinical outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available